Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
Heart Failure and Transplantation Program, Hospital 12 de Octubre, Madrid, Spain.
M A
MA
Gómez-Sánchez
J F
JF
Delgado
P
P
Escribano
M
M
Santos
T
T
Sotelo
R
R
Gil
J
J
Hernández-Afonso
B
B
Ortuño
F
F
Romero
C
C
Sáenz de la Calzada
J E
JE
Rodriguez
J J
JJ
Rufilanchas
D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D006439:Hemodynamics; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011184:Postoperative Period; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D008775:Methylprednisolone